Federated Hermes’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Federated Hermes’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,507	Closed	-$5K	–	2351
2021 Q2	$5K	Sell	1,507 -730	-33%	-$2.31K	﹤0.01%	2038
2021 Q1	$7K	Buy	2,237 +1,449	+184%	+$4.83K	﹤0.01%	2042
2020 Q4	$2K	Buy	+788	New	+$1.3K	﹤0.01%	2140
2019 Q4	–	Sell	-738	Closed	-$1K	–	2332
2019 Q3	$1K	Sell	738 -1,570	-68%	-$2.14K	﹤0.01%	2150
2019 Q2	$4K	Hold	2,308	–	–	﹤0.01%	2027
2019 Q1	$4K	Hold	2,308	–	–	﹤0.01%	2013
2018 Q4	$3K	Hold	2,308	–	–	﹤0.01%	2060
2018 Q3	$6K	Hold	2,308	–	–	﹤0.01%	2043
2018 Q2	$4K	Buy	2,308 +117	+5%	+$236	﹤0.01%	2051
2018 Q1	$5K	Hold	2,191	–	–	﹤0.01%	1973
2017 Q4	$4K	Sell	2,191 -1,685	-43%	-$3.5K	﹤0.01%	2026
2017 Q3	$5K	Hold	3,876	–	–	﹤0.01%	1967
2017 Q2	$6K	Hold	3,876	–	–	﹤0.01%	1926
2017 Q1	$13K	Hold	3,876	–	–	﹤0.01%	1786
2016 Q4	$5K	Buy	3,876 +235	+6%	+$307	﹤0.01%	1946
2016 Q3	$6K	Buy	3,641 +2,768	+317%	+$4.25K	﹤0.01%	1906
2016 Q2	$1K	Buy	+873	New	+$4.08K	﹤0.01%	2060

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Federated Hermes's INFI Position: Q3 2021 in Review

Federated Hermes sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2021, closing a stake of 1,507 shares — an estimated $5K sold.

Federated Hermes first reported a position in INFI in Q2 2016 and held it in 17 quarters. The position peaked at $13K in Q1 2017. 107 funds tracked by Wall St. Rank hold INFI as of Q3 2021.

Federated Hermes reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Federated Hermes sold 1,507 Infinity Pharmaceuticals, Inc. shares in Q3 2021, an estimated $5K.
Federated Hermes first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2016 and held it in 17 quarters.
Federated Hermes's Infinity Pharmaceuticals, Inc. position peaked at $13K in Q1 2017.
107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2021.

Based on Federated Hermes's 13F filing for Q3 2021, filed 15 Nov 2021.